Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,288,708
-$4,174,017 QoQ
Shares Held
6,878
-37.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#412
of 1,327 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLSTATE CORP holds $63,475,982 across 75 Biotechnology names. REGN ranks #2 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,006 | $10,931,039 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
6,878 | $4,288,708 | |
| 3 | RPRX |
Royalty Pharma plc
|
58,143 | $3,260,078 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
16,120 | $3,018,953 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,185 | $2,463,930 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
63,116 | $2,233,675 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
45,639 | $2,146,858 | |
| 8 | MRNA |
Moderna, Inc.
|
29,980 | $2,099,499 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,288,708 | 6,878 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,462,725 | 10,953 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,915,611 | 7,664 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,122,569 | 3,775 | Shares | Sole | 2025-10-29 | |
| 2025-03-31 | $2,235,660 | 3,525 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,275,894 | 3,195 | Shares | Sole | 2025-02-12 | |
| 2024-06-30 | $373,115 | 355 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $341,683 | 355 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $317,062 | 361 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $305,318 | 371 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $266,578 | 371 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $306,482 | 373 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,119,001 | 4,323 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,925,630 | 4,247 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,392,303 | 4,047 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,918,697 | 4,179 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,823,245 | 9,221 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $449,648 | 743 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $509,947 | 913 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $606,565 | 1,282 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $572,485 | 1,185 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,089,891 | 1,947 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,835,401 | 2,943 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,021,014 | 2,091 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||